Myriad Genetics Inc
Myriad Genetics develops molecular diagnostic tests for disease risk assessment and treatment guidance across multiple medical specialties.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 9Latest story
November 2026
October 2026
September 2026
July 2026